NOVO NORDISK A S

Holdings History for Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)

Investment type: Equity / Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)
Latest Disclosed Shares Owned: 7,333,778 shares
Security Ownership %: 7.8%

Novo Nordisk A/S ownership in Innate Pharma SA Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)

04 Mar 2026 - Novo Nordisk A/S has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,333,778 shares of Innate Pharma SA Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares). This represents 7.8% ownership of the company. In their previous filing dated 21 Oct 2025, NOVO NORDISK A S had reported owning 8,895,649 shares, indicating a decrease of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Novo Nordisk A/S	7.8%	-18%		7,333,778	-1,561,871	-18%		13G/A	31 Dec 2025	04 Mar 2026, 16:45
Novo Nordisk A/S	9.6%			8,895,649				13G/A	14 Jul 2025	21 Oct 2025, 08:00